scroll to top.svgleft arrow.svgright arrow-1.svg
AAAAI logo.svg
Share
share_on_x_twitter.svgShare on Facebook.svgshare on Linkedin.svg
Search
Search.svg
result

Introducing Two New Member Experiences: Learning That Fits Your Life and Advocacy That Amplifies Your Voice

The American Academy of Allergy, Asthma & Immunology (AAAAI) is proud to introduce two new digital platforms that will expand how members learn, engage and influence the future of allergy/immunology care — AAAAI Ignite and AAAAI Advocate.
Ignite-log-horz-clr.jpg
AAAAI Ignite is powered by Evermed, a learning experience platform that delivers educational content in a personalized, on-demand format much like popular streaming services. Rather than sifting through disparate conference recordings or long courses, AAAAI Ignite offers a curated experience where content is easy to browse, searchable and tailored to your interests — bringing conference videos, webinars and other professional learning into a single, dynamic library with AI-driven recommendations. This approach enables members to consume educational content in brief, practical micro-learning moments — when and where it fits into your busy clinical and professional life.
Advocate-log-horiz-clr.jpg
AAAAI Advocate is built on the Quorum public affairs platform, a comprehensive advocacy software designed to simplify how members engage with policy and public affairs. AAAAI Advocate will empower you to turn your expertise and perspectives into meaningful action on issues that affect patients, practice sustainability and the allergy/immunology specialty overall.
Together, these platforms reflect AAAAI’s commitment to delivering engaging learning experiences and effective advocacy resources that support your professional growth and amplify the collective voice of allergist/immunologists. Stop by the AAAAI Continuing Education Center and the AAAAI Practice Management Hub at the 2026 AAAAI Annual Meeting in Philadelphia for a sneak peak of these innovative new tools and stay tuned for rollout details coming soon.